Scientific Committee
The Scientific Committee acts as the supervisory body authority of the CoBi.
The tasks of the Scientific Committee are:
-
- Providing scientific evaluation of research projects
- Providing guidance on steps to be taken in case of individual incidental genetic findings
Prior to the approval, the research request of a Principal Investigator has to pass through a completeness check (Access Application Form) and a compliance check according the Access Policy of the CoBi.
The decision to approve a research request will be taken solely by the Scientific Committee within a time frame of four weeks and a maximum time frame of 8 weeks in the event of change requests or queries.
The Scientific Committee consists of seven votes in total and four membership groups:
-
-
- Transplantation Centres (represented by 2 votes, elected by all Transplantation Centres involved in the CoBi)
- DKMS Group gGmbH (represented by 2 fixed votes)
- Immunogeneticists (2 votes)
- Statistician (1 vote)
-
Projects will be evaluated exclusively with respect to the scientific merit and impact on the defined research framework of the Collaborative Biobank. Specifically, the following issues shall be evaluated:
-
-
- Is the current knowledge with respect to the research question summarized correctly?
- Is the hypothesis of the research purpose formulated precisely?
- Is the proposed methodology appropriate?
- Is the statistical plan conclusive?
- What might be the impact on future donor selection?
-
The Scientific Committee is quorate if at least 4 votes are cast.
For the coordination and administration of the Scientific Committee, DKMS Group gGmbH, Clinical Trials Unit undertakes all Committee Secretary Processes (e.g. compile background documents, count votes, draw-up approval notices).
Current members of the Scientific Committee:
Name | Affiliation |
PD Dr. med. Gesine Bug |
University Hospital Frankfurt, Medical Clinical II |
Prof. Dr. med. Katharina Fleischhauer |
University Hospital Essen, Haematolgy and Stem Cell Transplantation, Institute for Cell Therapy Research |
Dr. Vinzenz Lange | DKMS Life Science Lab gGmbH |
Prof. Dr. Hein Putter | Leids Universitair Medisch Centrum (LUMC) |
Univ.-Prof. Dr. med. Johannes Schetelig | DKMS Clinical Trials Unit & University Hospital Carl Gustav Carus Dresden, Medical Clinic I |
Univ.-Prof. Dr. med. Matthias Stelljes | University Hospital Muenster, Head of Bone Marrow Transplant Centre |
Prof. Dr. Robert Zeiser | University Hospital Freiburg, Department of Medicine I, Haematology, Oncology, and Stem Cell Transplantation |